GFAP and early-onset autosomal dominant Alzheimer disease: Serum glial fibrillary acidic protein (GFAP), as an intermediate filament of mature astrocytes, associates with cognitive decline in neurological disorders such as Alzheimer’s disease, reflecting disease-related reactive astrogliosis [10] and astroglial damage in the brain [11,12].